In this article, we will take a look at the 10 Safest Dividend Stocks to Buy Right Now.
Securing a predictable income while managing volatility is becoming the most adopted strategy for investors in the increasingly challenging economic environment. Currently, macroeconomic pressures continue to strain household purchasing power, while equity market gains remain highly unpredictable and concentrated in a select group of sectors.
One notable driver, at present, pushing the shift toward capital preservation is inflationary pressure. In a CNBC interview broadcast on May 27, 2026, Minneapolis Federal Reserve President Neel Kashkari emphasized that curbing inflation remains the central bank’s top priority. He labeled consumer prices as “much too high.” Kashkari stated that headline inflation in the U.S. reached 3.8% in April 2026 and attributed the rise to rising global energy and fertilizer prices. He strongly believes that the Federal Reserve must remain aggressive to anchor long-term inflation expectations.
When consumer price indices remain elevated and traditional asset valuations face upward pressure from a rising cost of capital, dividend stocks with reliable payments become a haven for investors. Benjamin Graham, the legendary Father of Value Investing, gave the following quote in his book The Intelligent Investor:
(True investor) … will do better if he forgets about the stock market and pays attention to his dividend returns and to the operating results of his companies.
Against this backdrop, we have identified 10 safest dividend stocks to buy right now for consistent income.
Our Methodology
To compile our list of 10 safest dividend stocks to buy right now, we listed dividend stocks with a beta of less than 0.60. A higher beta suggests greater volatility in market events, which increases potential risk. We further filtered the list by dividend yield and ranked them accordingly. We limited our final selection to companies that have recently reported noteworthy developments likely to impact investor sentiment. All the pricing data are current as of market close on May 28, 2026.
Why are we interested in the stocks that hedge funds pile into? The reason is simple: our research has shown that we can outperform the market by imitating the top stock picks of the best hedge funds. Our quarterly newsletter’s strategy selects 14 small-cap and large-cap stocks every quarter and has returned 498.7% since May 2014, beating its benchmark by 303 percentage points (see more details here).
10. Gilead Sciences, Inc. (NASDAQ:GILD)
Beta: 0.33
Dividend Yield: 2.45%
Ex. Dividend Date: June 15, 2026
Gilead Sciences, Inc. (NASDAQ:GILD) is one of the 10 safest dividend stocks to buy right now.
On May 21, 2026, Gilead Sciences, Inc. (NASDAQ:GILD) announced that the company, together with its subsidiary Kite, will present over 25 abstracts at the 2026 ASCO Annual Meeting (May 29 – June 2) and the EHA Congress (June 11 – 14), showcasing progress in cancer therapies. Key ASCO presentations include new late-stage Phase 3 analyses for Trodelvy in first-line metastatic triple-negative breast cancer, focusing on long-term progression-free survival. For the first time, Kite will also introduce manufacturing consistency data for anito-cel, an investigational CAR T-cell therapy for multiple myeloma. In addition, EHA updates will showcase the results regarding the durability and safety of an enhanced CAR T-cell therapy called KITE-753 that targets relapsed/refractory B-cell lymphoma.
In a recent development, Gilead Sciences, Inc. (NASDAQ:GILD) announced new Phase 3 interim data showing Livdelzi achieved high and sustained normalization of a key liver marker (ALP) in primary biliary cholangitis patients. According to the results, the drug was well-tolerated over two years of treatment.
Founded in 1987 and headquartered in California, Gilead Sciences Inc. (NASDAQ:GILD) is a drug manufacturer that develops medicines for unmet medical needs. The company provides treatments for HIV-1, chronic hepatitis C, primary biliary cholangitis, chronic hepatitis B, and serious invasive fungal infections. It has paid uninterrupted quarterly dividends for ten consecutive years.
Hedge Fund Resource Center